Varespladib inhibits secretory phospholipase A2 in bronchoalveolar lavage of different types of neonatal lung injury.
about
Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational studyEx vivo effect of varespladib on secretory phospholipase A2 alveolar activity in infants with ARDSNovel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model. A translational study.Snake Venom PLA2, a Promising Target for Broad-Spectrum Antivenom Drug Development.Description of an Automated Method for Urea Nitrogen Determination in Bronchoalveolar Lavage Fluid (BALF) of Neonates and Infants.
P2860
Varespladib inhibits secretory phospholipase A2 in bronchoalveolar lavage of different types of neonatal lung injury.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Varespladib inhibits secretory ...... types of neonatal lung injury.
@en
Varespladib inhibits secretory ...... types of neonatal lung injury.
@nl
type
label
Varespladib inhibits secretory ...... types of neonatal lung injury.
@en
Varespladib inhibits secretory ...... types of neonatal lung injury.
@nl
prefLabel
Varespladib inhibits secretory ...... types of neonatal lung injury.
@en
Varespladib inhibits secretory ...... types of neonatal lung injury.
@nl
P2093
P2860
P50
P356
P1476
Varespladib inhibits secretory ...... types of neonatal lung injury
@en
P2093
Cecilia Zuppi
Giorgio Conti
Joaquim Trias
Study Group on Secretory Phospholipase in Pediatrics
P2860
P304
P356
10.1177/0091270011405498
P577
2011-05-20T00:00:00Z